Cormorant Asset Management, 10% Owner: Immuneering IMRX Sell · Filed 24/03/18

Trade details

Type: Insider sale
Amount: $1,118,661.84
Shares · price: 345,266 sh · $3.24 a share
Held after: 3,859,098 sh
Stock: Immuneering IMRX
Person: Cormorant Asset Management10% Owner
Trade date: 24/03/14
Filed: 24/03/18
Days to filing: 4 days

Sold 8.2% of holdings

Share of holding sold: 8.2%

Immuneering trades, last 26 weeks

What else happened in Immuneering around then

Filed or reported within 30 days of the trade day · 24/02/13~24/04/13

Cormorant Asset Management's recent trades

Cormorant Asset ManagementOther
SellBright Minds Biosciences
Sell
Bright Minds Biosciences
DRUG
$9.8M
109,331 sh
$9.8M
Filed 04/30
Traded 04/28
Cormorant Asset Management10% Owner
SellCorbus Pharmaceuticals Holdings
Sell
Corbus Pharmaceuticals Holdings
CRBP
$344.1K
30,029 sh
$344.1K
Filed 25/12/15
Traded 25/12/11
Cormorant Asset ManagementOther
SellEyePoint
Sell
EyePoint
EYPT
$942K
60,000 sh
$942K
Filed 25/12/08
Traded 25/12/04
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$25.7M
3,390,943 sh
$25.7M
Filed 25/10/01
Traded 25/09/29
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$18.5M
2,800,000 sh
$18.5M
Filed 25/10/01
Traded 25/09/29

Cormorant Asset Management, 10% Owner — sold $1.1M of Immuneering IMRX · 8.2% of holdings | Whalegun